Ezallor Sprinkle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sun Pharmaceutical Industries announced the U. S. launch of the website for its long-term care (LTC) division, www.sunltc.com. The new website presents Sun Pharma s LTC portfolio of alternative formulation products and underscores Sun Pharma s commitment to meeting the needs of the up to 40% of American adults who cannot or will not swallow solid medication forms. Sun Pharma s LTC portfolio includes the first and only U. S. Food and Drug Administration (FDA)- approved extended-release sprinkle formulation of metoprolol succinate; the first and only FDA approved sprinkle formulation of delayed-release duloxetine; and the first and only approved sprinkle formulation of rosuvastatin, Ezallor Sprinkle (rosuvastatin) immediate-release

United statesSun pharmaSun pharmaceutical industriesDrug administrationEzallor sprinkleCapital marketLtc financial partners27th infantry regimentUs food and drug administrationFormulation productsSoft food alternative modeWww sunltc comஒன்றுபட்டது மாநிலங்களில்சூரியன் பார்மாசூரியன் மருந்து தொழில்கள்மூலதனம் சந்தை